Breaking Down Barriers: Aurora Cannabis Eases Patient Access to High Quality Medical Cannabis Products in Australia

Date:

NASDAQ | TSX: ACB
Largest Global Medical Cannabis Company Operating in Nationally Regulated Markets, Aurora Removes Concession Card Requirements to Access IndiMed Products in Australia
EDMONTON, AB, Feb. 14, 2025 /PRNewswire/ – Aurora Cannabis Inc. (the “Company” or “Aurora”) (NASDAQ:ACB) (TSX:ACB), the Canadian-based leading global medical cannabis company, in conjunction with MedReleaf Australia, recently removed the concession card requirement for patients to access medical cannabis products under the Company’s IndiMed brand. By removing this eligibility barrier, any patient in Australia can now be prescribed IndiMed products, providing greater patient access to high quality medical can

Read more…

Share post:

Subscribe

spot_imgspot_img

Popular

More like this
Related

Tampa RV giant Lazydays to delist from Nasdaq

Tampa-based Lazydays Holdings Inc., one of Florida’s most recognized...

Granite Geek: New Hampshire might get access to ‘balcony solar’

I had solar panels put on my roof six...

TSX Today: What to Watch for in Stocks on Monday, November 10

Despite firm gold and silver prices, Canadian stocks...

While BNB and DOT Struggle Under Market Pressure, BlockDAG’s Presale Soars Past $435M!

As market-wide fear grips the sector, the Binance Coin...